Meet our amazing speaker Dr. Qun Dang will be present his speaker presentation on “Azvudine, a novel nucleoside as effective treatment for HIV and COVID-19 infections with potential for liver cancer.” at the 14GASTROUCG Conference, from December 17-19, 2024 in Holiday Inn Dubai, Al Barsha, UAE & Virtual
As the 14th World Gastroenterology , IBD & Hepatology Conference approaches, the spotlight is on cutting-edge research shaping the future of medicine. Among the most anticipated presentations is Dr. Qun Dang's poster on “Azvudine, a Novel Nucleoside as Effective Treatment for HIV and COVID-19 Infections with Potential for Liver Cancer.” This innovative research delves into the multifaceted therapeutic potential of Azvudine, a compound poised to revolutionize treatments for infectious diseases and cancer. A Game-Changer for HIV and COVID-19 Azvudine, a novel nucleoside analog, has shown remarkable efficacy in combating HIV and COVID-19: HIV : By targeting viral replication, Azvudine provides a new approach to managing HIV, with the potential to enhance treatment regimens. COVID-19 : Amid ongoing challenges in treating SARS-CoV-2, Azvudine has demonstrated significant antiviral activity, offering hope for improved clinical outcomes. Potential Beyond Infect...